Skip to content
777 Sourcing.

Capability

neuroprotection therapeutics development

Suppliers
1
States & provinces
1
Countries
1

1 neuroprotection therapeutics development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

DECKTHERAPEUTICS, INC

HASTINGS ON HUDSON, NY

DeckTherapeutics is pioneering the new field of acute omega-3 fatty acid therapeutics. Its proprietary semi-synthetic omega-3 compounds are formulated as emulsions administered intravenously, exerting immediate effect on molecular pathways controlling cellular apoptosis and necrosis. Its lead candidate THDG3, developed at Columbia University, is a neuroprotectant with lead indication neonatal hypoxic-ischemic encephalopathy (HIE), with potential uses in ischemic stroke and other hypoxic-ischemic brain injuries.

intravenous emulsion formulationin vitro and in vivo studies

Compiled from public sources

Related capabilities

Other processes offered by the shops that list neuroprotection therapeutics development.

Browse all capabilities